Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
57.00
+1.58 (2.85%)
Aug 12, 2026, 12:10 PM EDT - Market open
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,480 employees as of June 30, 2026. The number of employees increased by 78 or 5.56% since the number was reported on December 31, 2025.
Employees
1,480
Change
78
Growth
5.56%
Revenue / Employee
$590,603
Profits / Employee
-$381,874
Market Cap
9.47B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,480 | 78 | 5.56% |
| Dec 31, 2025 | 1,402 | 333 | 31.15% |
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Crinetics Pharmaceuticals | 594 |
| Vaxcyte | 507 |
| Immunovant | 315 |
| Krystal Biotech | 295 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
IONS News
- 3 days ago - IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
- 9 days ago - Ionis Pharmaceuticals price target raised to $76 from $72 at JPMorgan - TheFly
- 13 days ago - Ionis Pharmaceuticals price target raised to $93 from $90 at BofA - TheFly
- 13 days ago - Ionis Pharmaceuticals price target lowered to $115 from $125 at H.C. Wainwright - TheFly
- 13 days ago - Ionis Pharmaceuticals price target raised to $69 from $66 at Goldman Sachs - TheFly
- 14 days ago - Ionis Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Ionis Pharmaceuticals Earnings release: Q2 2026 - Filings
- 14 days ago - Ionis Pharmaceuticals Slides: Q2 2026 - Filings